214 related articles for article (PubMed ID: 35674962)
1. In Vivo Skin Colonization and Decolonization Models for Candida auris.
Herrada J; Gamal A; Long L; Ghannoum MA
Methods Mol Biol; 2022; 2517():269-285. PubMed ID: 35674962
[TBL] [Abstract][Full Text] [Related]
2. An Immunocompromised Mouse Model of Candida auris Systemic Infection.
Herrada J; Roberts K; Gamal A; Long L; Ghannoum MA
Methods Mol Biol; 2022; 2517():317-328. PubMed ID: 35674965
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of chlorhexidine in advanced performance technology formulation in decolonizing the skin using Candida auris skin colonization mouse model.
Elshaer M; Herrada J; Gamal A; McCormick TS; Ghannoum M
Am J Infect Control; 2023 Jul; 51(7):836-837. PubMed ID: 36417953
[TBL] [Abstract][Full Text] [Related]
4. Drosophila melanogaster as a Rapid and Reliable In Vivo Infection Model to Study the Emerging Yeast Pathogen Candida auris.
Wurster S; Albert ND; Kontoyiannis DP
Methods Mol Biol; 2022; 2517():299-316. PubMed ID: 35674964
[TBL] [Abstract][Full Text] [Related]
5. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
Xin H; Rosario-Colon JA; Eberle K
mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
[TBL] [Abstract][Full Text] [Related]
6. Host defense mechanisms against
Pechacek J; Lionakis MS
Expert Rev Anti Infect Ther; 2023; 21(10):1087-1096. PubMed ID: 37753840
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Sharma D; Paul RA; Rudramurthy SM; Kashyap N; Bhattacharya S; Soman R; Shankarnarayan SA; Chavan D; Singh S; Das P; Kaur H; Ghosh AK; Prasad R; Sanyal K; Chakrabarti A
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0165221. PubMed ID: 34780273
[TBL] [Abstract][Full Text] [Related]
8. Dissemination of Candida auris to deep organs in neonatal murine invasive candidiasis.
Flores-Maldonado O; González GM; Andrade A; Montoya A; Treviño-Rangel R; Silva-Sánchez A; Becerril-García MA
Microb Pathog; 2021 Dec; 161(Pt B):105285. PubMed ID: 34774701
[TBL] [Abstract][Full Text] [Related]
9. Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.
Fernandes L; Ribeiro R; Henriques M; Rodrigues ME
Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1371-1385. PubMed ID: 36198878
[TBL] [Abstract][Full Text] [Related]
10. Tools and techniques to identify, study, and control Candida auris.
Carty J; Chowdhary A; Bernstein D; Thangamani S
PLoS Pathog; 2023 Oct; 19(10):e1011698. PubMed ID: 37856418
[TBL] [Abstract][Full Text] [Related]
11. Modeling Candida auris Colonization on Porcine Skin Ex Vivo.
Johnson CJ; Cheong JZA; Shanmuganayagam D; Kalan LR; Nett JE
Methods Mol Biol; 2022; 2517():251-258. PubMed ID: 35674960
[TBL] [Abstract][Full Text] [Related]
12. Experimental Mouse Models of Disseminated Candida auris Infection.
Xin H; Mohiuddin F; Tran J; Adams A; Eberle K
mSphere; 2019 Sep; 4(5):. PubMed ID: 31484737
[TBL] [Abstract][Full Text] [Related]
13. Mouse Gastrointestinal Colonization Model for Candida auris.
Simantirakis SC; MacCallum DM
Methods Mol Biol; 2022; 2517():329-340. PubMed ID: 35674966
[TBL] [Abstract][Full Text] [Related]
14. The first invasive
Tsai YT; Lu PL; Tang HJ; Huang CH; Hung WC; Tseng YT; Lee KM; Lin SY
Emerg Microbes Infect; 2022 Dec; 11(1):1867-1875. PubMed ID: 35811508
[No Abstract] [Full Text] [Related]
15. Mechanisms of pathogenicity for the emerging fungus Candida auris.
Horton MV; Holt AM; Nett JE
PLoS Pathog; 2023 Dec; 19(12):e1011843. PubMed ID: 38127686
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an
Ghannoum M; Isham N; Angulo D; Borroto-Esoda K; Barat S; Long L
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718958
[No Abstract] [Full Text] [Related]
17. A Human Ex Vivo Skin Model to Study Candida auris Biofilms.
Corzo-León DE; Mark C; MacCallum DM; Munro CA
Methods Mol Biol; 2022; 2517():259-267. PubMed ID: 35674961
[TBL] [Abstract][Full Text] [Related]
18. Ex Vivo Human and Porcine Skin Effectively Model Candida auris Colonization, Differentiating Robust and Poor Fungal Colonizers.
Eix EF; Johnson CJ; Wartman KM; Kernien JF; Meudt JJ; Shanmuganayagam D; Gibson ALF; Nett JE
J Infect Dis; 2022 May; 225(10):1791-1795. PubMed ID: 35267041
[TBL] [Abstract][Full Text] [Related]
19. Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.
Tsay S; Kallen A; Jackson BR; Chiller TM; Vallabhaneni S
Clin Infect Dis; 2018 Jan; 66(2):306-311. PubMed ID: 29020224
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
